News from NORD

Collaborative Effort Is Underway to Screen Small Molecules for Therapeutic Potential for NGLY1 Deficiency

Publish date: December 7, 2017

 

A collaboration involving a patient organization (NGLY1.org), government (NIH National Center for Advancing Translational Sciences) and industry (Retrophin) is underway to screen hundreds of thousands of small molecules for their therapeutic potential in NGLY1 deficiency.

Recommended Reading

NORD Publishes Three New Free Rare Disease Guides for Physicians
MDedge Pediatrics
Report on Li-Fraumeni Syndrome Now Available From NORD
MDedge Pediatrics
NORD Leads Campaign to Save Orphan Drug Tax Credit
MDedge Pediatrics
Webinar Recording on Open Enrollment Available
MDedge Pediatrics
Nominate a Colleague or Patient for a NORD Rare Impact Award
MDedge Pediatrics
NORD Reopens Call for Abstracts for Research Grants
MDedge Pediatrics
Poster Abstracts Due January 31 for European Conference on Rare Diseases and Orphan Products
MDedge Pediatrics
Beta Version of ClinicalTrials.gov Website Available for Public Testing
MDedge Pediatrics
NORD Welcomes Five New Member Organizations
MDedge Pediatrics
15th International Symposium on MPS and Related Diseases Is Planned
MDedge Pediatrics